In today's first round match-up of The Motley Fool Better-Buy Tournament, Enterprise Products Partners squares off against Amgen in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each as they make the case for their stocks with the winner determined by you, the readers.
Motley Fool energy analyst Joel South thinks Enterprise Products Partners (EPD -1.86%) is the premier MLP investment in today's market. With an industry leading low cost of capital, Enterprise Products Partners is able to safely fund growth projects without having to increase its debt leverage ratio. This gives unit holders piece of mind while they collect hefty distribution yields every quarter. In fact, with access to cheap capital, no general partner to pay management fees to, and a booming North American oil and gas industry, Enterprise Products Partners has increased its distribution for 38 consecutive quarters.
Motley Fool analyst Max Macaluso makes the case for Amgen (AMGN -0.66%) to move on to the next round. The company has matured into one of the biggest biotechs on the planet through its solid lineup of blockbuster drugs, and it has continued to diversify its drug pipeline. In addition, Amgen is one of the few biotechs to offer a dividend.
Watch these analysts square off in the video below and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket.
This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Cast your vote in the poll below the video!
